M Strnad Selected Research

zinc- tetrakis(p- sulfonatophenyl)porphyrin

10/2005	Photodynamic therapy with zinc-tetra(p-sulfophenyl)porphyrin bound to cyclodextrin induces single strand breaks of cellular DNA in G361 melanoma cells.
10/2003	In vitro toxicity testing of supramolecular sensitizers for photodynamic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Strnad Research Topics

Disease

6	Neoplasms (Cancer) 10/2007 - 11/2000
4	Melanoma (Melanoma, Malignant) 10/2007 - 10/2003
4	Phototoxic Dermatitis (Phototoxicity) 10/2007 - 10/2003
3	Prostatic Neoplasms (Prostate Cancer) 01/2010 - 01/2002
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2008
1	Adenocarcinoma 10/2007
1	Carcinoma (Carcinomatosis) 01/2004
1	Castration-Resistant Prostatic Neoplasms 08/2002
1	Leukemia 11/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2000
1	Acute-Phase Reaction 07/2000
1	Wounds and Injuries (Trauma) 07/2000

Drug/Important Bio-Agent (IBA)

3	olomoucineIBA 01/2004 - 11/2000
2	AndrogensIBA 01/2010 - 08/2002
2	phthalocyanineIBA 10/2007 - 03/2007
2	aluminum phthalocyanine disulfonateIBA 10/2007 - 03/2007
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2007 - 10/2005
2	Oxygen (Dioxygen)IBA 10/2007 - 10/2005
2	zinc- tetrakis(p- sulfonatophenyl)porphyrinIBA 10/2005 - 10/2003
2	ZincIBA 10/2005 - 10/2003
2	2-Hydroxypropyl-beta-cyclodextrinIBA 10/2005 - 10/2003
2	Hormones (Hormone)IBA 01/2004 - 01/2002
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2004 - 11/2000
2	bohemineIBA 08/2002 - 11/2000
2	Proteins (Proteins, Gene)FDA Link 01/2002 - 11/2000
1	PyrimidinesIBA 01/2016
1	Therapeutic UsesIBA 01/2010
1	Butyric Acid (Butanoic Acid)IBA 01/2010
1	Histone Deacetylase InhibitorsIBA 01/2010
1	theasinensin AIBA 01/2010
1	trichostatin A (A 300)IBA 01/2010
1	Androgen Receptors (Androgen Receptor)IBA 01/2010
1	Apoptosis Regulatory ProteinsIBA 07/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2007
1	DNA (Deoxyribonucleic Acid)IBA 10/2005
1	CyclodextrinsIBA 10/2005
1	PorphyrinsIBA 10/2005
1	Androgen Antagonists (Antiandrogens)IBA 01/2004
1	UraniumIBA 01/2004
1	bicalutamide (Casodex)FDA LinkGeneric 01/2004
1	tetraphenylporphine sulfonate (TPPS)IBA 10/2003
1	Cytostatic AgentsIBA 03/2002
1	CytokininsIBA 03/2002
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2002
1	Pharmaceutical PreparationsIBA 03/2001
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2000
1	Peptide Initiation Factors (Initiation Factor)IBA 11/2000
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 11/2000
1	rho Guanine Nucleotide Dissociation Inhibitor alphaIBA 11/2000
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 07/2000
1	HaptoglobinsIBA 07/2000
1	Interleukin-6 (Interleukin 6)IBA 07/2000
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2000
1	Interleukin-1 (Interleukin 1)IBA 07/2000

Therapy/Procedure

3	Photochemotherapy (Photodynamic Therapy) 10/2007 - 10/2005
2	Lasers (Laser) 10/2007 - 03/2007
1	Drug Therapy (Chemotherapy) 03/2002
1	Therapeutics 01/2002
1	Aftercare (After-Treatment) 11/2000
1	Tourniquets 07/2000